
Pomerantz LLP is investigating Boston Scientific for potential securities fraud after the company missed Q3 2026 earnings estimates and lowered guidance due to a major cybersecurity incident and operational challenges. The stock dropped nearly 6% following the announcement. The investigation seeks to determine if company officers engaged in unlawful practices affecting investors.
Boston Scientific Corporation (BSX) shares are trading at USD 43.08 on Pluang as of Nov 18, 2026 05:21 WIB. The stock shows a 1-day decline of 1.40%, with a market cap of $63.33 billion. Most Pluang users are selling, with 97% of order activity on the platform being sell orders.